市場調查報告書

iPS細胞的全球市場

Induced Pluripotent Stem Cell (iPSC)

出版商 Global Industry Analysts, Inc. 商品編碼 893747
出版日期 內容資訊 英文 397 Pages
商品交期: 最快1-2個工作天內
價格
iPS細胞的全球市場 Induced Pluripotent Stem Cell (iPSC)
出版日期: 2020年02月01日內容資訊: 英文 397 Pages
簡介

全球誘導性多功能幹細胞(iPS細胞)市場,預計以5.8%的複合成長率成長5億9,210萬美元。已開發國家美國維持6.2%的成長率,歐洲也持續維持世界經濟重要的地位。一般認為中國今後數年將成長7.6%。

本報告提供全球誘導性多功能幹細胞(iPS細胞)市場相關調查,市場概要和各市場區隔趨勢,各地區趨勢,及主要企業的簡介相關資訊。

第1章 簡介,調查方法,調查範圍

第2章 摘要整理

  • 市場概要
    • 幹細胞,應用領域,各種種類
    • 幹細胞的用途
    • 幹細胞的種類
    • 誘導性多功能幹細胞(iP細胞):簡介
    • iPS細胞的生產
    • iPS細胞的特性
    • 成長預測
    • 藥物開發的應用
    • 技術性突破,臨床實驗趨勢
    • 北美獨佔市場
    • 競爭
    • 近幾年的市場活動
  • 主要加入企業
  • 市場趨勢和促進因素
    • 在治療領域的急速成長
    • 研究趨勢
    • ES細胞相關疑慮提高對iPS細胞的關注
    • 再生醫療
    • 個體化開發藥劑中iPS細胞的重要性 其他
  • 全球市場預測
  • 市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 亞太地區
    • 南美
    • 中東
    • 非洲

第4章 競爭

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP12568

Induced Pluripotent Stem Cell (iPSC) market worldwide is projected to grow by US$592.1 Million, driven by a compounded growth of 5.8%. Vascular Cells, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$589.9 Million by the year 2025, Vascular Cells will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over *US$46.1 Million to the region's size and clout in the next 5 to 6 years. *Over US$40.3 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Vascular Cells will reach a market size of US$72.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.6% over the next couple of years and add approximately US$24.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • Axol Bioscience Ltd.
  • Cynata Therapeutics Limited
  • Evotec SE
  • Fate Therapeutics, Inc.
  • FUJIFILM Cellular Dynamics, Inc.
  • Ncardia
  • Pluricell Biotech
  • REPROCELL USA, Inc.
  • Shenzhen Sanqi Biotechnology Co., Ltd.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • ViaCyte, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE 1

II. EXECUTIVE SUMMARY 13

1. MARKET OVERVIEW 13

  • Stem Cells, Application Areas, and the Different Types: A Prelude 13
  • Applications of Stem Cells 13
  • Types of Stem Cells 14
  • Induced Pluripotent Stem Cell (iPSC): An Introduction 15
  • Production of iPSCs 16
  • First & Second Generation Mouse iPSCs 16
  • Human iPSCs 16
  • Key Properties of iPSCs 17
  • Transcription Factors Involved in Generation of iPSCs 17
  • Noteworthy Research & Application Areas for iPSCs 17
  • Induced Pluripotent Stem Cell ((iPSC) Market: Growth Prospects and Outlook 19
  • Drug Development Application to Witness Considerable Growth 21
  • Technical Breakthroughs, Advances & Clinical Trials to Spur Growth of iPSC Market 21
  • North America Dominates Global iPSC Market 22
  • Competition 22
  • Recent Market Activity 23

2. FOCUS ON SELECT PLAYERS 24

  • Axol Bioscience Ltd. (UK) 24
  • Cynata Therapeutics Limited (Australia) 24
  • Evotec SE (Germany) 24
  • Fate Therapeutics, Inc. (USA) 24
  • FUJIFILM Cellular Dynamics, Inc. (USA) 25
  • Ncardia (Belgium) 25
  • Pluricell Biotech (Brazil) 25
  • REPROCELL USA, Inc. (USA) 25
  • Shenzhen Sanqi Biotechnology Co., Ltd. (China) 26
  • Sumitomo Dainippon Pharma Co., Ltd. (Japan) 26
  • Takara Bio, Inc. (Japan) 26
  • Thermo Fisher Scientific, Inc. (USA) 27
  • ViaCyte, Inc. (USA) 27

3. MARKET TRENDS & DRIVERS 28

  • Induced Pluripotent Stem Cells: A Giant Leap in the Therapeutic Applications 28
  • Research Trends in Induced Pluripotent Stem Cell Space 28
  • EXHIBIT 1: Worldwide Publication of hESC and hiPSC Research Papers for the Period 2008-2010, 2011-2013 and 2014-2016 29
  • EXHIBIT 2: Number of Original Research Papers on hESC and iPSC Published Worldwide (2014-2016) 29
  • Concerns Related to Embryonic Stem Cells Shift the Focus onto iPSCs 30
  • Regenerative Medicine: A Promising Application of iPSCs 30
  • Induced Pluripotent: A Potential Competitor to hESCs? 32
  • EXHIBIT 3: Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025 34
  • EXHIBIT 4: Global Stem Cell & Regenerative Medicine Market by Product (in %) for the Year 2019 34
  • EXHIBIT 5: Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2019 35
  • Pluripotent Stem Cells Hold Significance for Cardiovascular Regenerative Medicine 35
  • EXHIBIT 6: Leading Causes of Mortality Worldwide: Number of Deaths in Millions & % Share of Deaths by Cause for 2017 37
  • Leading Causes of Mortality for Low-Income and High-Income Countries 37
  • Growing Importance of iPSCs in Personalized Drug Discovery 38
  • Persistent Advancements in Genetics Space and Subsequent Growth in Precision Medicine Augur Well for iPSCs Market 40
  • EXHIBIT 7: Global Precision Medicine Market (In US$ Billion) for the Years 2018, 2021 & 2024 41
  • Increasing Prevalence of Chronic Disorders Supports Growth of iPSCs Market 41
  • EXHIBIT 8: Worldwide Cancer Incidence: Number of New Cancer Cases Diagnosed for 2012, 2018 & 2040 42
  • EXHIBIT 9: Number of New Cancer Cases Reported (in Thousands) by Cancer Type: 2018 43
  • EXHIBIT 10: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others 44
  • EXHIBIT 11: Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045 45
  • Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for iPSCs Market 45
  • EXHIBIT 12: Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030 46
  • Growth in Number of Genomics Projects Propels Market Growth 46
  • Genomic Initiatives in Select Countries 47
  • EXHIBIT 13: New Gene-Editing Tools Spur Interest and Investments in Genetics, Driving Lucrative Growth Opportunities for iPSCs: Total VC Funding (In US$ Million) in Genetics for the Years 2014, 2015, 2016, 2017 and 2018 48
  • Launch of Numerous iPSCs-Related Clinical Trials Set to Benefit Market Growth 48
  • Number of Induced Pluripotent Stem Cells based Studies by Condition 50
  • Clinical Trials with Cells Derived from Human-Induced Pluripotent Stem Cells 50
  • iPSCs-based Clinical Trial for Heart Diseases 50
  • Induced Pluripotent Stem Cells for Stroke Treatment 51
  • 'Off-the-shelf' Stem Cell Treatment for Cancer Enters Clinical Trial 51
  • iPSCs for Hematological Disorders 51
  • Market Benefits from Growing Funding for iPSCs-Related R&D Initiatives 51
  • EXHIBIT 14: Stem Cell Research Funding in the US (in US$ Million) for the Years 2011 through 2017 53
  • Human iPSC Banks: A Review of Emerging Opportunities and Drawbacks 54
  • EXHIBIT 15: Human iPSC Banks Worldwide: An Overview 55
  • Cell Sources and Reprogramming Methods Used by Select iPSC Banks 56
  • Innovations, Research Studies & Advancements in iPSCs 57
  • Key iPSC Research Breakthroughs for Regenerative Medicine 57
  • Researchers Develop Novel Oncogene-Free and Virus-Free iPSC Production Method 58
  • Scientists Study Concerns of Genetic Mutations in iPSCs 59
  • iPSCs Hold Tremendous Potential in Transforming Research Efforts 60
  • Researchers Highlight Potential Use of iPSCs for Developing Novel Cancer Vaccines 61
  • Scientists Use Machine Learning to Improve Reliability of iPSC Self-Organization 61
  • STEMCELL Technologies Unveils mTeSR(tm) Plus 62
  • Challenges and Risks Related to Pluripotent Stem Cells 63
  • A Glance at Issues Related to Reprogramming of Adult Cells to iPSCs 64
  • A Note on Legal, Social and Ethical Considerations with iPSCs 65

4. GLOBAL MARKET PERSPECTIVE 66

  • TABLE 1: Induced Pluripotent Stem Cell (iPSC) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 66
  • TABLE 2: Induced Pluripotent Stem Cell (iPSC) Market Share Shift across Key Geographies Worldwide: 2019 VS 2025 67
  • TABLE 3: Vascular Cells (Cell Type) World Market by Region/Country in US$ Thousand: 2018 to 2025 68
  • TABLE 4: Vascular Cells (Cell Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025 69
  • TABLE 5: Cardiac Cells (Cell Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 70
  • TABLE 6: Cardiac Cells (Cell Type) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025 71
  • TABLE 7: Neuronal Cells (Cell Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025 72
  • TABLE 8: Neuronal Cells (Cell Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025 73
  • TABLE 9: Liver Cells (Cell Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025 74
  • TABLE 10: Liver Cells (Cell Type) Market Share Breakdown by Region/Country: 2019 VS 2025 75
  • TABLE 11: Immune Cells (Cell Type) World Market by Region/Country in US$ Thousand: 2018 to 2025 76
  • TABLE 12: Immune Cells (Cell Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025 77
  • TABLE 13: Other Cell Types (Cell Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025 78
  • TABLE 14: Other Cell Types (Cell Type) Market Percentage Share Distribution by Region/Country: 2019 VS 2025 79
  • TABLE 15: Cellular Reprogramming (Research Method) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025 80
  • TABLE 16: Cellular Reprogramming (Research Method) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025 81
  • TABLE 17: Cell Culture (Research Method) World Market by Region/Country in US$ Thousand: 2018 to 2025 82
  • TABLE 18: Cell Culture (Research Method) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025 83
  • TABLE 19: Cell Differentiation (Research Method) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 84
  • TABLE 20: Cell Differentiation (Research Method) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025 85
  • TABLE 21: Cell Analysis (Research Method) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025 86
  • TABLE 22: Cell Analysis (Research Method) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025 87
  • TABLE 23: Cellular Engineering (Research Method) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025 88
  • TABLE 24: Cellular Engineering (Research Method) Market Share Breakdown by Region/Country: 2019 VS 2025 89
  • TABLE 25: Other Research Methods (Research Method) World Market by Region/Country in US$ Thousand: 2018 to 2025 90
  • TABLE 26: Other Research Methods (Research Method) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025 91
  • TABLE 27: Drug Development & Toxicology Testing (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025 92
  • TABLE 28: Drug Development & Toxicology Testing (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2019 VS 2025 93
  • TABLE 29: Academic Research (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025 94
  • TABLE 30: Academic Research (Application) Market Share Shift across Key Geographies: 2019 VS 2025 95
  • TABLE 31: Regenerative Medicine (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025 96
  • TABLE 32: Regenerative Medicine (Application) Market Share Breakdown by Region/Country: 2019 VS 2025 97
  • TABLE 33: Other Applications (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025 98
  • TABLE 34: Other Applications (Application) Share Breakdown Review by Region/Country: 2019 VS 2025 99

III. MARKET ANALYSIS 100

  • GEOGRAPHIC MARKET ANALYSIS 100
  • UNITED STATES 100
  • TABLE 35: United States Induced Pluripotent Stem Cell (iPSC) Market Estimates and Projections in US$ Thousand by Cell Type: 2018 to 2025 100
  • TABLE 36: United States Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025 101
  • TABLE 37: United States Induced Pluripotent Stem Cell (iPSC) Market Estimates and Projections in US$ Thousand by Research Method: 2018 to 2025 102
  • TABLE 38: United States Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025 103
  • TABLE 39: United States Induced Pluripotent Stem Cell (iPSC) Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 104
  • TABLE 40: Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown in the United States by Application: 2019 VS 2025 105
  • CANADA 106
  • TABLE 41: Canadian Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018 to 2025 106
  • TABLE 42: Induced Pluripotent Stem Cell (iPSC) Market in Canada: Percentage Share Breakdown of Sales by Cell Type for 2019 and 2025 107
  • TABLE 43: Canadian Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018 to 2025 108
  • TABLE 44: Induced Pluripotent Stem Cell (iPSC) Market in Canada: Percentage Share Breakdown of Sales by Research Method for 2019 and 2025 109
  • TABLE 45: Canadian Induced Pluripotent Stem Cell (iPSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 110
  • TABLE 46: Canadian Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025 111
  • JAPAN 112
  • TABLE 47: Japanese Market for Induced Pluripotent Stem Cell (iPSC): Annual Sales Estimates and Projections in US$ Thousand by Cell Type for the Period 2018-2025 112
  • TABLE 48: Japanese Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025 113
  • TABLE 49: Japanese Market for Induced Pluripotent Stem Cell (iPSC): Annual Sales Estimates and Projections in US$ Thousand by Research Method for the Period 2018-2025 114
  • TABLE 50: Japanese Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025 115
  • TABLE 51: Japanese Demand Estimates and Forecasts for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025 116
  • TABLE 52: Induced Pluripotent Stem Cell (iPSC) Market Share Shift in Japan by Application: 2019 VS 2025 117
  • CHINA 118
  • TABLE 53: Chinese Induced Pluripotent Stem Cell (iPSC) Market Growth Prospects in US$ Thousand by Cell Type for the Period 2018-2025 118
  • TABLE 54: Chinese Induced Pluripotent Stem Cell (iPSC) Market by Cell Type: Percentage Breakdown of Sales for 2019 and 2025 119
  • TABLE 55: Chinese Induced Pluripotent Stem Cell (iPSC) Market Growth Prospects in US$ Thousand by Research Method for the Period 2018-2025 120
  • TABLE 56: Chinese Induced Pluripotent Stem Cell (iPSC) Market by Research Method: Percentage Breakdown of Sales for 2019 and 2025 121
  • TABLE 57: Chinese Demand for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025 122
  • TABLE 58: Chinese Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Application: 2019 VS 2025 123
  • EUROPE 124
  • TABLE 59: European Induced Pluripotent Stem Cell (iPSC) Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 124
  • TABLE 60: European Induced Pluripotent Stem Cell (iPSC) Market Share Shift by Region/Country: 2019 VS 2025 125
  • TABLE 61: European Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018-2025 126
  • TABLE 62: European Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025 127
  • TABLE 63: European Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018-2025 128
  • TABLE 64: European Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025 129
  • TABLE 65: European Induced Pluripotent Stem Cell (iPSC) Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 130
  • TABLE 66: European Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025 131
  • FRANCE 132
  • TABLE 67: Induced Pluripotent Stem Cell (iPSC) Market in France by Cell Type: Estimates and Projections in US$ Thousand for the Period 2018-2025 132
  • TABLE 68: French Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025 133
  • TABLE 69: Induced Pluripotent Stem Cell (iPSC) Market in France by Research Method: Estimates and Projections in US$ Thousand for the Period 2018-2025 134
  • TABLE 70: French Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025 135
  • TABLE 71: Induced Pluripotent Stem Cell (iPSC) Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025 136
  • TABLE 72: French Induced Pluripotent Stem Cell (iPSC) Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025 137
  • GERMANY 138
  • TABLE 73: Induced Pluripotent Stem Cell (iPSC) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Cell Type for the Period 2018-2025 138
  • TABLE 74: German Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025 139
  • TABLE 75: Induced Pluripotent Stem Cell (iPSC) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Research Method for the Period 2018-2025 140
  • TABLE 76: German Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025 141
  • TABLE 77: Induced Pluripotent Stem Cell (iPSC) Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 142
  • TABLE 78: Induced Pluripotent Stem Cell (iPSC) Market Share Distribution in Germany by Application: 2019 VS 2025 143
  • ITALY 144
  • TABLE 79: Italian Induced Pluripotent Stem Cell (iPSC) Market Growth Prospects in US$ Thousand by Cell Type for the Period 2018-2025 144
  • TABLE 80: Italian Induced Pluripotent Stem Cell (iPSC) Market by Cell Type: Percentage Breakdown of Sales for 2019 and 2025 145
  • TABLE 81: Italian Induced Pluripotent Stem Cell (iPSC) Market Growth Prospects in US$ Thousand by Research Method for the Period 2018-2025 146
  • TABLE 82: Italian Induced Pluripotent Stem Cell (iPSC) Market by Research Method: Percentage Breakdown of Sales for 2019 and 2025 147
  • TABLE 83: Italian Demand for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025 148
  • TABLE 84: Italian Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Application: 2019 VS 2025 149
  • UNITED KINGDOM 150
  • TABLE 85: United Kingdom Market for Induced Pluripotent Stem Cell (iPSC): Annual Sales Estimates and Projections in US$ Thousand by Cell Type for the Period 2018-2025 150
  • TABLE 86: United Kingdom Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025 151
  • TABLE 87: United Kingdom Market for Induced Pluripotent Stem Cell (iPSC): Annual Sales Estimates and Projections in US$ Thousand by Research Method for the Period 2018-2025 152
  • TABLE 88: United Kingdom Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025 153
  • TABLE 89: United Kingdom Demand Estimates and Forecasts for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025 154
  • TABLE 90: Induced Pluripotent Stem Cell (iPSC) Market Share Shift in the United Kingdom by Application: 2019 VS 2025 155
  • REST OF EUROPE 156
  • TABLE 91: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018-2025 156
  • TABLE 92: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025 157
  • TABLE 93: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018-2025 158
  • TABLE 94: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025 159
  • TABLE 95: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 160
  • TABLE 96: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025 161
  • ASIA-PACIFIC 162
  • TABLE 97: Induced Pluripotent Stem Cell (iPSC) Market in Asia-Pacific by Cell Type: Estimates and Projections in US$ Thousand for the Period 2018-2025 162
  • TABLE 98: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025 163
  • TABLE 99: Induced Pluripotent Stem Cell (iPSC) Market in Asia-Pacific by Research Method: Estimates and Projections in US$ Thousand for the Period 2018-2025 164
  • TABLE 100: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025 165
  • TABLE 101: Induced Pluripotent Stem Cell (iPSC) Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025 166
  • TABLE 102: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025 167
  • REST OF WORLD 168
  • TABLE 103: Rest of World Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018 to 2025 168
  • TABLE 104: Induced Pluripotent Stem Cell (iPSC) Market in Rest of World: Percentage Share Breakdown of Sales by Cell Type for 2019 and 2025 169
  • TABLE 105: Rest of World Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018 to 2025 170
  • TABLE 106: Induced Pluripotent Stem Cell (iPSC) Market in Rest of World: Percentage Share Breakdown of Sales by Research Method for 2019 and 2025 171
  • TABLE 107: Rest of World Induced Pluripotent Stem Cell (iPSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 172
  • TABLE 108: Rest of World Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025 173

IV. COMPETITION

  • Total Companies Profiled : 45 (including Divisions/Subsidiaries - 46)
  • INDUCED PLURIPOTENT STEM CELL (iPSC) MCP12568
  • CONTENTS